Weight Loss in Parkinson's Disease: No Evidence for Role of Small Intestinal Bacterial Overgrowth. [electronic resource]
Producer: 20191017Description: 571-581 p. digitalISSN:- 1877-718X
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- therapeutic use
- Bacterial Infections -- complications
- Cross-Sectional Studies
- Female
- Humans
- Intestine, Small -- microbiology
- Male
- Middle Aged
- Parkinson Disease -- complications
- Quality of Life
- Rifaximin -- therapeutic use
- Treatment Outcome
- Weight Loss -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.